# The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease

> **NCT01876108** · PHASE2 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Fatty Liver
- Liver Dysfunction
- Insulin Resistance

## Interventions

- **DRUG:** H.pylori eradication (Omeprazole, Amoxicillin, Bismuth subcitrate, Azithromycin)

## Key facts

- **NCT ID:** NCT01876108
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01876108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01876108, "The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01876108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*